Gonzalez Flecha B, Llesuy S, Boveris A
Institute of Biochemistry and Biophysics, School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina.
Free Radic Biol Med. 1991;10(2):93-100. doi: 10.1016/0891-5849(91)90002-k.
Hydroperoxide-initiated chemiluminescence was standardized as a microassay to evaluate the occurrence of oxidative stress in human biopsies. Samples of 10 to 50 mg of rat liver or heart were homogenized, diluted in reaction medium, added with tert-butyl hydroperoxide, and assayed for chemiluminescence in a liquid scintillation counter in the out-of-coincidence mode. Optimal conditions for the assay were: 0.3 to 1.2 mg/mL of homogenate protein in 120 mM KCl, 30 mM phosphate buffer (pH 7.4), and 3 mM tert-butyl hydroperoxide at 30 degrees C. In these conditions, maximal chemiluminescence values were 550 +/- 30 and 1100 +/- 40 cps/mg protein, for liver and heart homogenates, respectively. Liver and heart homogenates were subjected to in vitro oxidative stresses such as supplementation with organic hydroperoxide or with enzymatic systems generating superoxide anion or hydrogen peroxide. Chemiluminescence was higher in the poststress samples than in the control ones. The ratio: poststress chemiluminescence/control chemiluminescence (B/A) was about 1.4 or higher for both tissues. Human heart biopsies were utilized to investigate the occurrence of oxidative stress after clinical situations associated to ischemia-reperfusion. B/A ratios were 2.1 +/- 0.4, 1.4 +/- 0.1, and 2.8 +/- 0.4 for human heart, liver, and skeletal muscle, respectively.
过氧化氢引发的化学发光被标准化为一种微量测定法,用于评估人体活检组织中氧化应激的发生情况。取10至50毫克大鼠肝脏或心脏样本进行匀浆,在反应介质中稀释,加入叔丁基过氧化氢,然后在液体闪烁计数器中以非符合模式测定化学发光。该测定的最佳条件为:在120 mM氯化钾、30 mM磷酸盐缓冲液(pH 7.4)中,匀浆蛋白浓度为0.3至1.2毫克/毫升,30℃下加入3 mM叔丁基过氧化氢。在这些条件下,肝脏和心脏匀浆的最大化学发光值分别为550±30和1100±40 cps/毫克蛋白。对肝脏和心脏匀浆施加体外氧化应激,如补充有机过氧化氢或添加产生超氧阴离子或过氧化氢的酶系统。应激后样本的化学发光高于对照样本。两种组织的应激后化学发光/对照化学发光比值(B/A)约为1.4或更高。利用人体心脏活检组织研究与缺血再灌注相关的临床情况后氧化应激的发生情况。人体心脏、肝脏和骨骼肌的B/A比值分别为2.1±0.4、1.4±0.1和2.8±0.4。